antibiotics
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
| 4 min read
Another biotech retreats from AAV, a promising antibiotic, a paused CRISPR trial, and more led the news this week.
| 4 min read
Researchers are turning bacterial transport systems from obstacles into opportunities for targeted therapy.
| 2 min read
Nearly 25 percent of non-antibiotic drugs tested in the study enabled the proliferation of enteropathogens.
| 2 min read
Real-world data and KOL insights highlight MeMed BV’s supportive role in emergency medicine
| 3 min read
After decades of stalled innovation, a new oral antibiotic could now combat both everyday infections and urgent public health threats.
| 2 min read
Antibiotics target bacteria, but new work in mice shows they also harm the mucus layer that protects the intestinal lining from microbes.
| 9 min read
New phenotypic methods can help identify the best antibiotic to treat sepsis, UTIs, and other bacterial infections.
| 3 min read
In vivo studies of the antibiotic darobactin D22 against high-priority gram-negative bacteria show promise for further drug development.
